AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $0.91 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2022-03-30
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2021 was $0.91, a 25.41% decline from fiscal 2020.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2020 was $1.22, a 0.00% change from fiscal 2019.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2019 was $1.22.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2021-12-31 | $0.91 10-K · filed 2022-03-30 |
| 2020-12-31 | $1.22 10-K · filed 2022-03-30 |
| 2019-12-31 | $1.22 10-K · filed 2021-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |